Kronos Worldwide, Inc. — 2016 Form 10-K Summary
Business context and reporting period
Fiscal year ended December 31, 2016; filed March 10, 2017. Kronos is a global producer and marketer of titanium dioxide (TiO₂), used mainly in coatings, plastics and paper. TiO₂ accounted for approximately 93% of 2016 sales. The company reported annual results, not a standalone “2016 Q4” filing; quarterly figures are noted below.
Key financial metrics
| Metric | 2016 | 2015 |
|---|---|---|
| Net sales | $1,364.3 million | $1,348.8 million |
| Gross margin | $257.0 million; 19% of sales | $192.3 million; 14% of sales |
| Operating income (loss) | $81.1 million; 6% of sales | $(1.1) million |
| Net income (loss) | $43.3 million; $0.37 per share | $(173.6) million; $(1.50) per share |
| Cash from operating activities | $89.6 million | $52.1 million |
| Capital expenditures | $53.0 million | $47.1 million |
| Total debt, including current maturities | $339.0 million | $341.0 million |
| Cash and cash equivalents at year-end | $50.7 million | $92.5 million |
Sales volume rose 7% to 559,000 metric tons; production increased 3% to 546,000 metric tons, with capacity utilization at 98%. Average TiO₂ selling prices declined 3% year over year, though year-end prices were 10% above year-end 2015. Gross margin improved to approximately 18.8% of sales, and operating margin was approximately 5.9%.
Fourth-quarter 2016 sales were $333.7 million, gross margin $85.6 million and net income $23.2 million ($0.20 per share). Fourth-quarter 2015 sales were $287.0 million, gross margin $25.2 million and net loss $20.4 million ($(0.18) per share).
Material changes versus the prior comparable period
- Annual sales increased 1%, as 7% higher sales volumes more than offset a 3% decline in average TiO₂ prices, unfavorable product mix and approximately $9 million of currency-related sales impact.
- Operating income improved by $82.2 million. Lower feedstock and other production costs, higher volumes, savings from 2015 workforce reductions, favorable currency effects on operating income and $4.3 million in insurance settlements contributed to the improvement.
- 2015 results included a $159.0 million non-cash deferred-tax valuation allowance charge for German and Belgian operations, a $12.0 million pre-tax impairment of a marketable equity security and $21.7 million of workforce-reduction charges. These items materially affect year-over-year net income comparisons.
- Operating cash flow increased $37.5 million, while year-end cash and cash equivalents declined $41.8 million. The filing attributes cash movements in part to financing, capital spending, dividends and exchange-rate effects.
Outlook, risks and unusual items
- Management expected 2017 production to be slightly higher and sales volumes comparable to 2016, assuming economic conditions did not deteriorate. It expected 2017 operating income to exceed 2016, principally from higher average selling prices and, to a lesser extent, higher production volumes. Cost of sales per metric ton was expected to be comparable to slightly higher.
- Management stated that a sustained improvement in German results could support reversal of some or all of the German deferred-tax valuation allowance during 2017, potentially producing a material non-cash tax benefit; timing and amount were uncertain. The Belgian business continued to have cumulative losses over the most recent 12 quarters.
- At year-end, debt was primarily a variable-rate term loan due in February 2020. The company reported $74.8 million of North American revolving availability and approximately $58.5 million of European revolving availability; it was in compliance with debt covenants. The European facility matured in September 2017, and management expected to obtain an extension.
- Cash and cash equivalents were $50.7 million, with another $1.6 million classified as restricted cash. Contractual commitments totaled $1.239 billion, including $433.4 million due in 2017; these include debt, interest, leases, supply contracts and other obligations. Management expected sufficient liquidity for near- and long-term obligations.
- Feedstock supply and cost, TiO₂ pricing and demand cycles, competition, currency movements, energy costs, production interruptions, environmental regulation and refinancing/liquidity are key risks. Minimum purchase commitments included approximately $605 million for TiO₂ feedstock and $158 million for other long-term supply and service contracts.
- Defined-benefit pension obligations were materially underfunded: non-U.S. plan funded status was $(222.6) million and the U.S. plan $(4.2) million. Management expected approximately $15 million in pension and OPEB contributions in 2017.
- Two pending antitrust cases allege price-fixing in TiO₂ sales. Kronos denied the allegations and stated that it had not accrued a loss because a material loss was not considered reasonably possible. The filing also describes ongoing tax examinations and environmental and other claims.
- The company paid $0.60 per share in dividends in 2016 and declared a $0.15-per-share dividend for first-quarter 2017. Future dividends remain subject to board discretion and financial conditions.
Most important facts for investors to verify
- Whether TiO₂ price increases achieved late in 2016 continued through 2017, and how realized pricing compared with management’s outlook.
- Whether sales volumes, capacity utilization and demand supported the expected 2017 operating-income improvement.
- Cash generation and liquidity after dividends, capital expenditures, pension funding and contractual purchasing commitments; confirm the extension or refinancing of the European credit facility.
- Progress toward sustained German profitability and any resulting change in the deferred-tax valuation allowance; monitor Belgian results and uncertain tax positions.
- Developments in the pending antitrust litigation, raw-material supply contracts, environmental obligations and the company’s significant pension deficit.